Scinai Immunotherapeutics (SCNI)

• Market cap: $3.36M
• 1 day: 1.03%
• 5 days: -2.97%
• 1 month: 36.7%
• 3 months: -32.88%
• 6 months: -39.13%
• Year to date: 34.34%
• 1 year: -72.16%
• 5 years: -99.8%
• 10 years: -99.71%
• Sector: Healthcare
• Industry: Biotechnology

About: Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Employees: 31